Skip to main content
NVDA-4.54%AAPL+1.08%GOOGL-3.67%MSFT-2.34%AMZN-4.97%TSM-4.82%SPCX-9.14%META-7.57%AVGO-4.83%TSLA-2.24%LLY+2.89%BRK-B+1.52%MU-6.89%SKHY-8.60%WMT+2.72%JPM+0.03%AMD-8.65%V+1.40%XOM-0.12%JNJ+4.18%ASMLa-4.74%MA+1.62%ABBV-0.14%INTC-8.70%COST+1.96%CVX-0.07%0700.HK-2.89%1398.HK-1.34%CSCO-2.25%KO+2.75%PG+5.75%ORCL-3.77%UNH+1.85%BAC+0.27%1816.HK-0.22%3988.HK-1.80%HD+4.10%CAT-5.15%0005.HK-1.23%HSBA.L-2.45%PM+1.66%AP2d-6.79%0857.HK-0.82%AMAT-8.14%1288.HK-0.30%GE-1.12%0939.HK-0.61%NVS+1.46%LRCX-12.52%MS-1.95%PLNJPY-1.42%EURAUD-1.22%EURCAD-1.16%AUDUSD+1.02%USDCAD-0.95%EURJPY-0.91%USDTHB+0.86%SGDJPY-0.82%GBPZAR+0.78%USDZAR+0.78%CHFSEK+0.75%EURNZD-0.75%USDJPY-0.74%EURGBP-0.71%EURCHF-0.62%USDPLN+0.61%EURZAR+0.61%AUDCHF+0.59%NZDUSD+0.56%CADCHF+0.53%GBPUSD+0.51%GBPAUD-0.51%AUDNOK-0.49%CHFSGD+0.49%EURNOK-0.48%NOKJPY-0.48%AUDNZD+0.47%GBPCAD-0.46%EURPLN+0.46%USDCHF-0.43%GBPTRY+0.41%NZDCAD-0.40%CHFJPY-0.33%USDNOK-0.33%AUDJPY+0.33%GBPHKD+0.32%NZDSGD-0.30%GBPMXN-0.28%EURHKD-0.27%USDSEK+0.27%CADJPY+0.24%GBPJPY-0.22%USDTRY+0.21%EURUSD-0.20%USDCNH-0.19%NZDJPY-0.19%USDMXN+0.17%USDILS+0.16%EURCNH-0.16%AUDSGD-0.16%EURSGD-0.15%CHFNOK+0.15%NZDMXN-0.14%USDDKK+0.14%USDHKD-0.13%NZDCHF+0.11%EURSEK+0.11%GBPCHF+0.07%AUDCAD+0.07%GBPNZD-0.06%EURCZK+0.06%USDCOP-0.04%AUDDKK-0.02%GBPSGD+0.02%EURDKK-0.01%USDSGD+0.01%XAGUSD-5.84%GAGUSD-5.82%XPTUSD-3.82%GAUUSD-2.83%XAUUSD-2.83%HG1-2.74%UKOIL+2.56%USOIL+1.49%XNGUSD+0.22%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-3.13%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.69%ZECUSDT-8.07%DOGEUSD+14.39%XMRUSDT-1.75%LINKUSD+14.52%XLMUSD-4.08%BCHUSDT-4.23%LTCUSD+8.69%UNIUSD-5.80%SUIUSD-5.04%HBARUSDT-5.79%TONUSD+26.39%TAOUSDT-5.69%AAVEUSD-5.37%DOTUSDT-2.35%WLDUSDT-4.98%ICPUSDT-6.26%ONDOUSDT-6.87%ARBUSDT-4.21%JUPUSDT-5.17%ATOMUSDT-2.86%INJUSDT-6.86%STXUSDT-10.85%TIAUSDT-6.23%FETUSDT-5.90%PYTHUSDT-6.66%SEIUSDT-7.66%IMXUSDT-7.91%GRTUSDT-5.80%OPUSDT-7.98%WIFUSDT-6.52%IOTAUSDT-4.85%AXSUSDT-5.55%POLUSDT-4.65%FARTCOINUSDT-4.95%EOSUSDT-1.61%DYDXUSDT-6.13%GALAUSDT-5.61%ORDIUSDT-2.99%RONINUSDT-3.56%NOTUSDT-4.94%NVDA-4.54%AAPL+1.08%GOOGL-3.67%MSFT-2.34%AMZN-4.97%TSM-4.82%SPCX-9.14%META-7.57%AVGO-4.83%TSLA-2.24%LLY+2.89%BRK-B+1.52%MU-6.89%SKHY-8.60%WMT+2.72%JPM+0.03%AMD-8.65%V+1.40%XOM-0.12%JNJ+4.18%ASMLa-4.74%MA+1.62%ABBV-0.14%INTC-8.70%COST+1.96%CVX-0.07%0700.HK-2.89%1398.HK-1.34%CSCO-2.25%KO+2.75%PG+5.75%ORCL-3.77%UNH+1.85%BAC+0.27%1816.HK-0.22%3988.HK-1.80%HD+4.10%CAT-5.15%0005.HK-1.23%HSBA.L-2.45%PM+1.66%AP2d-6.79%0857.HK-0.82%AMAT-8.14%1288.HK-0.30%GE-1.12%0939.HK-0.61%NVS+1.46%LRCX-12.52%MS-1.95%PLNJPY-1.42%EURAUD-1.22%EURCAD-1.16%AUDUSD+1.02%USDCAD-0.95%EURJPY-0.91%USDTHB+0.86%SGDJPY-0.82%GBPZAR+0.78%USDZAR+0.78%CHFSEK+0.75%EURNZD-0.75%USDJPY-0.74%EURGBP-0.71%EURCHF-0.62%USDPLN+0.61%EURZAR+0.61%AUDCHF+0.59%NZDUSD+0.56%CADCHF+0.53%GBPUSD+0.51%GBPAUD-0.51%AUDNOK-0.49%CHFSGD+0.49%EURNOK-0.48%NOKJPY-0.48%AUDNZD+0.47%GBPCAD-0.46%EURPLN+0.46%USDCHF-0.43%GBPTRY+0.41%NZDCAD-0.40%CHFJPY-0.33%USDNOK-0.33%AUDJPY+0.33%GBPHKD+0.32%NZDSGD-0.30%GBPMXN-0.28%EURHKD-0.27%USDSEK+0.27%CADJPY+0.24%GBPJPY-0.22%USDTRY+0.21%EURUSD-0.20%USDCNH-0.19%NZDJPY-0.19%USDMXN+0.17%USDILS+0.16%EURCNH-0.16%AUDSGD-0.16%EURSGD-0.15%CHFNOK+0.15%NZDMXN-0.14%USDDKK+0.14%USDHKD-0.13%NZDCHF+0.11%EURSEK+0.11%GBPCHF+0.07%AUDCAD+0.07%GBPNZD-0.06%EURCZK+0.06%USDCOP-0.04%AUDDKK-0.02%GBPSGD+0.02%EURDKK-0.01%USDSGD+0.01%XAGUSD-5.84%GAGUSD-5.82%XPTUSD-3.82%GAUUSD-2.83%XAUUSD-2.83%HG1-2.74%UKOIL+2.56%USOIL+1.49%XNGUSD+0.22%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD-3.13%ETHUSD+16.36%USDTUSD-0.02%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.69%ZECUSDT-8.07%DOGEUSD+14.39%XMRUSDT-1.75%LINKUSD+14.52%XLMUSD-4.08%BCHUSDT-4.23%LTCUSD+8.69%UNIUSD-5.80%SUIUSD-5.04%HBARUSDT-5.79%TONUSD+26.39%TAOUSDT-5.69%AAVEUSD-5.37%DOTUSDT-2.35%WLDUSDT-4.98%ICPUSDT-6.26%ONDOUSDT-6.87%ARBUSDT-4.21%JUPUSDT-5.17%ATOMUSDT-2.86%INJUSDT-6.86%STXUSDT-10.85%TIAUSDT-6.23%FETUSDT-5.90%PYTHUSDT-6.66%SEIUSDT-7.66%IMXUSDT-7.91%GRTUSDT-5.80%OPUSDT-7.98%WIFUSDT-6.52%IOTAUSDT-4.85%AXSUSDT-5.55%POLUSDT-4.65%FARTCOINUSDT-4.95%EOSUSDT-1.61%DYDXUSDT-6.13%GALAUSDT-5.61%ORDIUSDT-2.99%RONINUSDT-3.56%NOTUSDT-4.94%
BI

Bioventus Inc. (BVS)

NASDAQ • Healthcare

$14.24
+$0.29 (+2.1%)
Market open

Last close at October 21, 2026 at 20:00 UTC

Open$13.83
Previous Close$14.24
Day Range$13.78 - $14.29
Avg. Volume (3M)388.2K
Market Cap$994.5M
P/E Ratio17.8
52 Week Range
$6.47$15.89
Next EarningsIn 12 daysNov 3, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$153.2M100%
Gross Profitminus cost of goods$105.6M69%
Operating Incomeminus R&D and overhead$19.1M12%
Net Incomeminus taxes and the rest$33.4M22%

In plain terms: out of every $100 in revenue, Bioventus Inc. keeps $22 as net profit.

Fundamentals & Financials

Revenue (TTM)
$581.8M
Net Income (TTM)
$54.4M
EPS (TTM)
$0.8
ROA (TTM)
8.09%
Current Ratio
1.69
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+9.1%Q1 2026$0.24
+66.7%Q2 2026$0.15
+1.7%Q3 2026$0.22
Next

Nov 3

in 12 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +1.7%

Bioventus’s adjusted EPS edged past consensus while revenue came in slightly below expectations in the second fiscal quarter of 2026, reported Aug. 5, with adjusted EPS of $0.22 versus the $0.22 estimate, about +1.7%, and up 4.8% from $0.21 a year ago. Revenue rose 3.8% to about $153.2 million from about $147.7 million a year earlier, but it missed the about $154.9 million consensus by 1.1%. Gross profit came in at about $105.7 million, leaving gross margin near 69%, and operating income was about $19.1 million with operating margin around 12.5%. The quarter also generated operating cash flow of about $28.8 million. Next-period consensus calls for EPS of $0.17 on revenue of $149.0 million.

Next report — what to expect

Bioventus Inc. (BVS) is set to report earnings on November 3, 2026. Wall Street’s next-period consensus calls for EPS of $0.17 on revenue of $149.5 million, with trailing context showing revenue rose +3.8% year over year last quarter. Bioventus has beaten EPS in 5 of 8 most recent quarters.

View full earnings history

About Bioventus Inc.

Bioventus Inc. (NASDAQ: BVS) develops and sells medical devices and restorative therapies aimed at pain relief and musculoskeletal care. Its portfolio spans osteoarthritis injections, peripheral nerve stimulation, surgical systems, bone graft substitutes, and bone healing products, and produced $568.1 million of revenue in FY2025.

Name
Bioventus Inc.
CEO
Robert Claypoole
Website
www.bioventus.com
Industry
Healthcare
Year Founded
2011
Employees
950

Today's Snapshot

AI-generated

BVS is trading 4.4% higher at 14.87, in line with a firmer sector. Earnings are due from BVS on 3 November.

Trading Volume

Below 10d avg (360.6K)

344.7K

vs S&P 500 Today

Strong Outperformance

+5.85%

Updated: October 22, 2026 at 19:13 UTC

Technical Indicators

6 Buy1 Neutral1 Sell
BVS is trading at 14.95 and is positioned above its short-, medium- and long-term moving averages, with OBV confirming that recent buying accompanied price advances. Momentum measures show strength—a very elevated CCI and a positive MACD—while RSI sits in a constructive range, so momentum is supportive even though ADX around 15 signals a weak trend. Volatility is moderate and the price sits near the upper Bollinger boundary, suggesting short-term overextension, while the classic pivot lies below the market. Technical takeaway: Buy.
All signals
  • EMA (5 indicators)$10.92 - $13.87
    Buy
  • RSI (14)65.95
    Neutral
  • Stochastic %K (14, 3, 3)97.55
    Sell
  • MACD Level (12, 26)0.19
    Buy

Peers & Related Assets

IARTIntegra LifeSciences Holdings Corporation
$11.84-11.2%
MDXGMiMedx Group, Inc.
$3.74-11.6%
OFIXOrthofix Medical Inc.
$9.74-1.1%
ANIKAnika Therapeutics, Inc.
$20.6+0.8%
ORGOOrganogenesis Holdings Inc.
$0.99-2.8%
SNNSmith & Nephew plc
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.